Business Context and Reporting Period
Company: cbdMD, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 1, 2023
Reporting Period: Event date February 1, 2023; Signed February 7, 2023.
The Company entered into a material definitive agreement for advertising placement services.
Key Financial Metrics
This filing does not report revenue, profit, cash flow, margins, debt, or liquidity metrics. It discloses a specific transaction involving equity issuance:
- Transaction Value: $2,000,000 in advertising credit.
- Equity Issued: Up to 6,060,606 shares of common stock.
- Valuation: Shares valued at $0.33 per share.
Material Changes
The primary material change is the entry into an agreement with a360 Media, LLC. The Company will receive $2,000,000 in media support and advertising placement credit in exchange for unregistered common stock. This represents a non-cash transaction impacting equity and potential future expenses or marketing assets.
Guidance, Outlook, and Risks
Agreement Terms and Vesting:
- 70% Vested: Fully vested immediately.
- 15% Performance Vesting: Vests pro-rata as advertising placement accrues.
- 15% Conditional Vesting: Vests if no restrictions exist on product categories the Company can market.
- Expiration: Advertising placement must be used by December 30, 2023.
- Forfeiture: Unvested shares are forfeited if conditions are not met within the term.
Regulatory Status: The shares were sold pursuant to exemptions under Section 4(a)(2) of the Securities Act of 1933 and applicable state laws; they are unregistered.
Management Commentary: The filing contains no forward-looking guidance or management commentary beyond the terms of the agreement.
Investor Verification Checklist
- Verify the impact of the 6,060,606 share issuance on total outstanding shares and potential dilution.
- Confirm the actual utilization rate of the $2,000,000 advertising credit by the December 30, 2023 deadline.
- Monitor the vesting status of the conditional 15% tranche regarding product category restrictions.
- Review the upcoming Form 10-Q for the quarter ended December 31, 2022, for the full text of the agreement and any related accounting treatment.